MP:0001272 | increased metastatic potential | |
Show
Allelic Composition: Patz1tm1.1Welm/Patz1tm1.1Welm,Tg(TcraTcrb)1100Mjb/0 Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0001790 | abnormal immune system physiology | "deviation from the normal function of the immune system " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Capn3tm1Jsb/Capn3+,Ttntm1.1Isrd/Ttntm1.1Isrd Genetic Background: involves: 129/Sv * 129S2/SvPas * C57BL/6
|
MP:0001828 | abnormal T cell activation | "anomaly in the process of producing effector T cells from naive T cells" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Patz1tm1.1Welm/Patz1tm1.1Welm,Tg(TcraTcrb)1100Mjb/0 Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0002021 | increased incidence of induced tumors | "higher than normal frequency of tumor incidence induced by a carcinogen or mutagen" [J:44427] |
Show
Allelic Composition: Capn3tm1Jsb/Capn3+,Ttntm1.1Isrd/Ttntm1.1Isrd Genetic Background: involves: 129/Sv * 129S2/SvPas * C57BL/6
|
MP:0003721 | increased tumor growth/size | "greater than expected development of tumorous growth when compared to controls" [smb:Susan M Bello, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Patz1tm1.1Welm/Patz1tm1.1Welm,Tg(TcraTcrb)1100Mjb/0 Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0004499 | increased incidence of chemically-induced tumors | "higher than normal frequency of tumor incidence induced by one or more chemical carcinogens or mutagens" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Cd226tm1Shib/Cd226tm1Shib Genetic Background: involves: BALB/c
|
MP:0005070 | defective NK cell cytolysis | "impaired ability of these cells to destroy or dissolve targeted cells" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:6213] |
Show
Allelic Composition: Patz1tm1.1Welm/Patz1tm1.1Welm,Tg(TcraTcrb)1100Mjb/0 Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Cd226tm1Shib/Cd226tm1Shib Genetic Background: involves: BALB/c
|
MP:0005079 | defective cytotoxic T cell cytolysis | "impaired ability of these cells to destroy or dissolve targeted cells" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, J:6692] |
Show
Allelic Composition: Patz1tm1.1Welm/Patz1tm1.1Welm,Tg(TcraTcrb)1100Mjb/0 Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Cd226tm1Shib/Cd226tm1Shib Genetic Background: involves: BALB/c
|
MP:0005095 | decreased T cell proliferation | "reduced clonal expansion of naive T cells in response to stimuli" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Patz1tm1.1Welm/Patz1tm1.1Welm,Tg(TcraTcrb)1100Mjb/0 Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Cd226tm1.1Cln/Cd226tm1.1Cln,Tg(TcraTcrb)1100Mjb/0 Genetic Background: B6.Cg-Cd226tm1.1Cln Tg(TcraTcrb)1100Mjb
|
MP:0008567 | decreased interferon-gamma secretion | "reduction in the production or release of the major interferon produced by mitogenically or antigenically stimulated lymphocytes that is involved in immunoregulation" [MESH:D12.644.276.374.440.893] |
Show
Allelic Composition: Cd226tm1.1Cln/Cd226tm1.1Cln,Tg(TcraTcrb)1100Mjb/0 Genetic Background: B6.Cg-Cd226tm1.1Cln Tg(TcraTcrb)1100Mjb
|
MP:0009763 | increased sensitivity to induced morbidity/mortality | "decrease in the amount of an external agent required to cause death or diseased state" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Cd226tm1Shib/Cd226tm1Shib Genetic Background: involves: BALB/c
|